文献速递慢阻肺

血清透明质酸水平与慢阻肺严重程度相关并可预测生存

Serum levels of hyaluronic acid are associated with COPD severity and predict survival.
PubMed 文献 · Eur Respir J · 2019-03-07

在80例慢阻肺患者发现队列中,急性加重期血清透明质酸(HA)高于稳定期(p=0.015);在638例PROMISE验证队列中,中度和重度急性加重期HA均高于基线(p<0.001),且4周后仍较高(p<0.001)。HA与死亡时间独立相关(p<0.001),可预测总体生存。

要点

  • 慢阻肺急性加重期血清HA高于稳定期,且4周后仍较高。
  • 血清HA是慢阻肺总体生存的独立预测因素。
  • 稳定期HYAL-1酶活性与FEV1%pred及生存时间呈负相关。

核心结论

  • 血清HA与慢阻肺严重程度相关,并可预测总体生存。
  • HA降解与气流受限和肺功能损害相关。

研究设计与样本

  • 发现队列纳入80例慢阻肺患者,检测稳定期和急性加重期血清HA。
  • 验证队列纳入638例慢阻肺患者(PROMISE队列),在稳定期、急性加重期及加重后4周评估HA、HYAL-1及其酶活性。

主要发现

  • 发现队列中急性加重期血清HA高于稳定期(p=0.015)。
  • 验证队列中中度和重度急性加重期HA均高于基线(p<0.001),4周后仍较高(p<0.001)。
  • HA与死亡时间相关(p<0.001),独立于校正Charlson评分、年急性加重率和BODE指数。
  • 中度(p=0.004)和重度(p=0.003)急性加重期血清HYAL-1升高,4周后下降(p<0.001)。
  • 稳定期HYAL-1酶活性与FEV1%pred(p=0.034)和生存时间(p=0.017)呈负相关。

临床怎么用

  • 血清HA可作为评估慢阻肺严重程度和预测生存的潜在生物标志物。
  • 急性加重期HA升高且持续,提示需关注疾病活动性和预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hyaluronic acid (HA) and its degradation products play an important role in lung pathophysiology and airway remodelling in chronic obstructive pulmonary disease (COPD).We investigated if HA and its degrading enzyme hyaluronidase (HYAL)-1 are associated with COPD severity and outcome.Serum HA was assessed in a discovery cohort of 80 COPD patients at stable state and exacerbations. HA, HYAL-1 and HYAL-1 enzymatic activity were evaluated at stable state, exacerbations and 4 weeks after exacerbations in 638 COPD patients from the PROMISE validation cohort.In the discovery cohort, serum HA was higher at exacerbations compared with the stable state (p=0.015). In the validation cohort, HA was higher at moderate and severe exacerbations than at baseline (p<0.001), and remained higher after 4 weeks (p<0.001). HA was strongly predictive for overall survival since it was associated with time to death (p<0.001) independently of adjusted Charlson score, annual exacerbation rate and BODE (body mass, airflow obstruction, dyspnoea, exercise capacity) index. Serum HYAL-1 was increased at moderate (p=0.004) and severe (p=0.003) exacerbations, but decreased after 4 weeks (p<0.001). HYAL-1 enzymatic activity at stable state was inversely correlated with FEV1 % pred (p=0.034) and survival time (p=0.017).Serum HA is associated with COPD severity and predicts overall survival. Degradation of HA is associated with airflow limitation and impairment of lung function.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Papakonstantinou E, Bonovolias I, Roth M, et al. Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur Respir J. 2019. PMID: 30705130. doi:10.1183/13993003.01183-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。